You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 3, March 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE SECOND ANNUAL MEETING OF THE SURGICAL INFECTION SOCIETY, BOSTON, APRIL 19-20, 1982-PART II
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Nonspecific Stimulation of Host Defenses Against Bacterial Challenge in Immunosuppressed Mice

Robert B. Galland, FRCS; Kevin J. Heine; Hiram C. Polk, Jr, MD

Arch Surg. 1983;118(3):333-337.


Abstract

• Muramyl dipeptide (MDP) has been shown to be a safe and effective host defense stimulant in both normal and malnourished hosts exposed to a bacterial challenge. We investigated its effect in mice compromised by pretreatment with either cyclophosphamide or steroids. The bacterial challenge, designed to simulate a surgical wound infection, consisted of a Klebsiella pneumoniae-laden suture. The MDP treatment resulted in lower local and systemic bacterial spread and increased survival in mice immunosuppressed by cyclophosphamide than in untreated controls. No such effect was demonstrated in animals compromised by steroids. These results suggest that MDP exerts its effect primarily on the macrophage.

(Arch Surg 1983;118:333-337)



Author Affiliations

From the Department of Surgery and the Price Institute of Surgical Research, University of Louisville (Ky) School of Medicine. Dr Galland is now with Hammersmith Hospital, London.


Footnotes

Accepted for publication Sept 7, 1982.

Read before the second annual meeting of the Surgical Infection Society, April 20, 1982.

Reprint requests to Department of Surgery, Ambulatory Care Building, University of Louisville School of Medicine, Louisville, KY 40292.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Anti-CD3/Anti-CD28 Monoclonal Antibody-Coated Suture Enhances the Immune Response of Patients With Head and Neck Squamous Cell Carcinoma
Shibuya et al.
Arch Otolaryngol Head Neck Surg 1999;125:1229-1234.
ABSTRACT | FULL TEXT  

Effects of Muramyl Dipeptide and Core Body Temperature on Peritoneal Bacterial Clearance
Stellato et al.
Arch Surg 1988;123:465-469.
ABSTRACT  

Muramyl Dipeptide Enhances Survival From Experimental Peritonitis
Brown et al.
Arch Surg 1986;121:47-49.
ABSTRACT  

Effect of Abdominal Operations on Survival After Septic Challenge in Normal Rats
Selivanov and Sheldon
Arch Surg 1984;119:71-74.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.